Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
Tuomo Kallio

Tuomo Kallio

Benzinga Staff Writer

Why Finland Will Not Leave the Eurozone
Why Finland Will Not Leave the Eurozone
Five Investments for Higgs Boson
Five Investments for Higgs Boson
Tahoe Resources Sell-Off Could Be a Buying Opportunity
Tahoe Resources Sell-Off Could Be a Buying Opportunity
Teva Beats Momenta, Mylan in Copaxone Case
Teva Beats Momenta, Mylan in Copaxone Case
Did a Bear Raid Cause the Sell-Off in Arena Pharmaceuticals?
Did a Bear Raid Cause the Sell-Off in Arena Pharmaceuticals?
Rite Aid Rallies After Reporting Q1 Earnings
Rite Aid Rallies After Reporting Q1 Earnings
Is NVIDIA's Tablet-Fueled Rally Sustainable?
Is NVIDIA's Tablet-Fueled Rally Sustainable?
Meredith Whitney on Bloomberg: Dimon is Incredible, Still Bearish on Citi
Meredith Whitney on Bloomberg: Dimon is Incredible, Still Bearish on Citi
First Solar's Japanese-Fueled Rally is Misguided
First Solar's Japanese-Fueled Rally is Misguided
Three High-Risk/High-Reward Stocks for the Greek Elections
Three High-Risk/High-Reward Stocks for the Greek Elections
Kim Kardashian's Sexy Picture Validates Facebook's $1B Instagram Acquisition
Kim Kardashian's Sexy Picture Validates Facebook's $1B Instagram Acquisition
GM Switching from One Failing Ad Platform to Another?
GM Switching from One Failing Ad Platform to Another?
GSV Capital Sell Off Overdone?
GSV Capital Sell Off Overdone?
GSV Capital CEO: Facebook Only 4% of Overall Holdings
GSV Capital CEO: Facebook Only 4% of Overall Holdings
FOMC Minutes Send US Equities Lower
FOMC Minutes Send US Equities Lower
European ETFs Performing Sluggishly
European ETFs Performing Sluggishly
What Are the Earnings Numbers Telling Us About Long-Term Trends?
What Are the Earnings Numbers Telling Us About Long-Term Trends?
Starbucks Employee Benefits in China Could Also Benefit Shareholders
Starbucks Employee Benefits in China Could Also Benefit Shareholders
Are Raised Outlooks a Bullish Sign for Caterpillar?
Are Raised Outlooks a Bullish Sign for Caterpillar?
Could ViroPharma Benefit from Multiple Generic Versions of VANCOCIN?
Could ViroPharma Benefit from Multiple Generic Versions of VANCOCIN?
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved